Teal Health Teams Up With Thatch to Expand Access to Cervical Cancer Screening
Through a new partnership, Thatch’s employer customers can now offer Teal Health’s at-home cervical cancer screening as an employee benefit through an ICHRA.
Empowering Prevention: The Present and Future of Cervical Cancer Screening
HPV self-collection testing empowers more people to participate in their own care, fostering autonomy and helping to bridge long-standing gaps in access to screenings for all populations.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
FDA Approves First At-Home Cervical Cancer Test
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California.
Meet the Company Developing an At-Home Test to Replace the Pap Smear
Teal Health raised $10 million in seed funding, taking its total funding to $23 million. The company has submitted an application to the FDA for its at-home cervical cancer screening kit, which seeks to give patients an alternative to the in-office pap smear.
Seagen, Genmab antibody drug conjugate gets FDA approval in cervical cancer
The Seagen and Genmab antibody drug conjugate (ADC), named Tivdak, is approved to treat cases of cervical cancer that have returned or spread following treatment with chemotherapy. Tivdak is Seagen’s third ADC; for Genmab, the drug will become its first commercialized product.
New cervical cancer screening guidelines ignore past progress
It is unclear why the American Cancer Society would potentially impact the lives of countless women with recommendations that contradict decades of real progress.
presented by
MedCity News Pivot Podcast: How Emergency Departments Are Using Real-Time Data to Improve Outcomes
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Iovance could use ongoing Phase II trial to support FDA approval for cell therapy
The company said the agency told it that it may consider data from an amended version of the trial of LN-145 for approval. An analyst wrote that approval could happen in the first half of 2021, based on Iovance's guidance for regulatory submission.
Biop Medical raises $2.25M to advance development of mobile device to detect cervical cancer
The Series A financing round of $2.25 million will be used to move forward with the development of its point-of-care diagnostic tools for the accurate detection of epithelium cancers, with a primary focus on cervical cancer.
Genentech contest offers $50K to startups developing new approaches to cervical cancer
Genentech, whose drug Avastin is approved to treat advanced cervical cancer, has launched a contest offering $50K to startups with innovative approaches to address the disease.
Startup’s antiviral drug combats HPV, new study shows
San Diego startup Hera Therapeutics is developing a topical antiviral drug that attacks human papillomavirus – and early studies are showing it can successfully combat three strains, including two that cause 70 percent of all cervical cancer. The drug candidate, HTI-1968, blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to the NIAID-sponsored study. The work […]
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
March Startup Index: 12 companies making healthcare easier, faster, and less painful
You never want to be the last speaker at the end of a long conference day. Many people in the 4:30 slot even mention this strategic disadvantage, “I know I am standing between you and happy hour, so I’ll make it quick.” The best end-of-the-day speaker I have ever heard was Dr. Victor Montori at […]
Women could do cervical cancer screenings at home if this device makes it to market
Cervical cancer is the easiest female cancer to prevent, because there are highly effective vaccines available, and precancerous cells can be detected by Pap tests and treated before they turn into cancer. Yet, in some areas of the world with lower incomes, cervical cancer incidence rates are still high, partially because of limited access to […]